Shockwave Medical Seeks To Bolster Its Cardiovascular Disease Portfolio With Neovasc Acquisition

Shockwave Medical Inc (NASDAQ: SWAV) has agreed to acquire Neovasc Inc (NASDAQ: NVCN) for an upfront cash payment of $27.25 per share, corresponding to an enterprise value of approximately $100 millio...

U.S. Exports To Top $30 Billion For First Time In 2022

The month of September 2022 was a record for the month, easily surpassing the previous nine … [+] September totals. ustradenumbers.com U.S. exports of pills and other medicines in dosage form wi...

Covid-19 Linked To Increased Risk Of Developing Diabetes And Cardiovascular Disease, Study Finds

Topline People are more likely to develop cardiovascular disease and diabetes after falling ill with Covid-19, especially in the three months after being infected, British researchers found in a study...